<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>PathogenDx, Inc. News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/8557</link>
		<description>Latest news from PathogenDx, Inc., as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Wed, 11 Mar 2026 03:44:44 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/8557.jpg</url>
			<title>PathogenDx, Inc. News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/8557</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/8557"/>
		<item xml:lang="en">
			<title>PathogenDx Launches Novel D3 Array Multiplexed Molecular Diagnostics Technology for Urinary Tract Infection (UTI) Pathogen Detection and Antibiotic Resistance</title>
			<link>https://www.newsfilecorp.com/release/197070/PathogenDx-Launches-Novel-D3-Array-Multiplexed-Molecular-Diagnostics-Technology-for-Urinary-Tract-Infection-UTI-Pathogen-Detection-and-Antibiotic-Resistance</link>
			<description>Scottsdale, Arizona--(Newsfile Corp. - February 7, 2024) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of D3 Array™-UTI, a differentiated multiplexed PCR test that detects 26 pathogens and 12 antibiotic resistance gene markers to aid clinicians in delivering rapid UTI treatment. Powered by the Company's novel multiplexed molecular diagnostics technology, D3 Array™-UTI features testing in triplicate for quality assurance, with...&lt;img src="https://api.newsfilecorp.com/newsinfo/197070/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 07 Feb 2024 08:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/197070</guid>
		</item>
		<item xml:lang="en">
			<title>PathogenDx Launches the Cannabis Industry's First AOAC Certified Rapid Semi-Quantification Test for Total Yeast and Mold with Results in a Single-Shift</title>
			<link>https://www.newsfilecorp.com/release/183552/PathogenDx-Launches-the-Cannabis-Industrys-First-AOAC-Certified-Rapid-SemiQuantification-Test-for-Total-Yeast-and-Mold-with-Results-in-a-SingleShift</link>
			<description>New Assay Offers Automated Triplicate Testing, Extended Semi-Quantitation to 100,000 CFU/gram and Fastest Results to Market in One Efficient Test Scottsdale, Arizona--(Newsfile Corp. - October 11, 2023) - PathogenDx (PathogenDx or Company), a leader in next-generation microarray technology for better health and safety, announced the launch of its new and improved rapid semi-quantification assay, QuantX Fungal, which has received an AOAC® Performance Tested Methods (PTM) SM Certificate to...&lt;img src="https://api.newsfilecorp.com/newsinfo/183552/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 11 Oct 2023 08:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/183552</guid>
			<atom:subtitle>New Assay Offers Automated Triplicate Testing, Extended Semi-Quantitation to 100,000 CFU/gram and Fastest Results to Market in One Efficient Test</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>PathogenDx Enables Labs to Meet Cannabis Testing Regulations in Every State With Launch of Rapid Bacterial Semi-Quantification Four-in-One Test</title>
			<link>https://www.newsfilecorp.com/release/177189/PathogenDx-Enables-Labs-to-Meet-Cannabis-Testing-Regulations-in-Every-State-With-Launch-of-Rapid-Bacterial-SemiQuantification-FourinOne-Test</link>
			<description>Company Now Offers Cannabis' Most Comprehensive and Adaptable Microbial Testing Platform Scottsdale, Arizona--(Newsfile Corp. - August 15, 2023) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of QuantX Bacterial, a new rapid bacterial semi-quantification four-in-one assay that enables cannabis testing labs to efficiently meet any state's microbial testing regulations. The QuantX Bacterial assay simplifies a lab's workflow,...&lt;img src="https://api.newsfilecorp.com/newsinfo/177189/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 15 Aug 2023 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/177189</guid>
			<atom:subtitle>Company Now Offers Cannabis' Most Comprehensive and Adaptable Microbial Testing Platform</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>PathogenDx's New Rapid, Single Test Detects Salmonella and 13 Serotypes in Poultry as Foodborne Illness Remains a Significant Threat to Public Health in the US</title>
			<link>https://www.newsfilecorp.com/release/173344/PathogenDxs-New-Rapid-Single-Test-Detects-Salmonella-and-13-Serotypes-in-Poultry-as-Foodborne-Illness-Remains-a-Significant-Threat-to-Public-Health-in-the-US</link>
			<description>Serotypes Responsible for the Vast Majority of All Harmful Salmonella Infections Are Rapidly Identified in One Efficient Test - in One Lab Shift Scottsdale, Arizona--(Newsfile Corp. - July 13, 2023) - At a time when foodborne illness remains a significant threat to public health in the US, PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of SeroX, a new rapid, single test that detects Salmonella and 13 serotypes in a single shift to...&lt;img src="https://api.newsfilecorp.com/newsinfo/173344/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 13 Jul 2023 07:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/173344</guid>
			<atom:subtitle>Serotypes Responsible for the Vast Majority of All Harmful Salmonella Infections Are Rapidly Identified in One Efficient Test - in One Lab Shift</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors</title>
			<link>https://www.newsfilecorp.com/release/162020/PathogenDx-Expands-Reach-of-Its-Patented-Multiplexed-Molecular-Testing-Technology-Bringing-It-to-the-Clinical-Food-and-Agriculture-Sectors</link>
			<description>Company's Novel "Dynamic Dimensional Detection" Array Technology Delivers Unprecedented Performance in Multiplexing, Turn-Around Time, Throughput and Cost Per Test Scottsdale, Arizona--(Newsfile Corp. - April 12, 2023) - PathogenDx ("PathogenDx" or "Company"), a leader in next-generation microarray technology for better health and safety, announced it has expanded the reach of its patented multiplexed molecular testing technology - Dynamic Dimensional Detection ("D3 Array™") - beyond the...&lt;img src="https://api.newsfilecorp.com/newsinfo/162020/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 12 Apr 2023 11:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/162020</guid>
			<atom:subtitle>Company's Novel "Dynamic Dimensional Detection" Array Technology Delivers Unprecedented Performance in Multiplexing, Turn-Around Time, Throughput and Cost Per Test</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>With a Two-Year Revenue Growth of 276%, PathogenDx Ranks No. 50 on Inc. Magazine's List of the Southwest Region's Fastest-Growing Private Companies</title>
			<link>https://www.newsfilecorp.com/release/156311/With-a-TwoYear-Revenue-Growth-of-276-PathogenDx-Ranks-No.-50-on-Inc.-Magazines-List-of-the-Southwest-Regions-FastestGrowing-Private-Companies</link>
			<description>As Pathogens, Viruses and Superbugs Surge, the Microarray Technology Leader's Innovations Are Working to Address Some of the World's Most Urgent Challenges Scottsdale, Arizona--(Newsfile Corp. - February 28, 2023) - Inc. magazine revealed that PathogenDx ("PathogenDx" or "Company"), a leader in next-generation microarray technology for better health and safety, is No. 50 on its fourth annual Inc. 5000 Regionals Southwest list1, the most prestigious ranking of the fastest-growing private...&lt;img src="https://api.newsfilecorp.com/newsinfo/156311/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 28 Feb 2023 07:00:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/156311</guid>
			<atom:subtitle>As Pathogens, Viruses and Superbugs Surge, the Microarray Technology Leader's Innovations Are Working to Address Some of the World's Most Urgent Challenges</atom:subtitle>
		</item>
	</channel>
</rss>
